Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 511

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Mechanisms of antidiabetic effects of flavonoid rutin

Ghorbani, Ahmad·2017·Biomedicine & Pharmacotherapy

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2017.10.001

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 78

  1. Lotfy, 2017, Chronic complications of diabetes mellitus: a mini review, Curr. Diabetes Rev., 13, 3, 10.2174/1573399812666151016101622 · DOI · Paper page
  2. Vinayagam, 2015, Antidiabetic properties of dietary flavonoids: a cellular mechanism review, Nutr. Metab., 12, 60, 10.1186/s12986-015-0057-7 · DOI · Paper page
  3. Gullón, 2017, Rutin A review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability, Trends Food Sci. Technol., 67, 220, 10.1016/j.tifs.2017.07.008 · DOI · Paper page
  4. Selloum, 2003, Anti-inflammatory effect of rutin on rat paw oedema, and on neutrophils chemotaxis and degranulation, Exp. Toxicol. Pathol., 54, 313, 10.1078/0940-2993-00260 · DOI · Paper page
  5. Yang, 2008, In vitro antioxidant properties of rutin, LWT-Food Sci. Technol., 41, 1060, 10.1016/j.lwt.2007.06.010 · DOI · Paper page
  6. Alinejad, 2013, Effects of combinations of curcumin, linalool, rutin, safranal, and thymoquinone on glucose/serum deprivation-induced cell death, Avicenna J. Phytomed., 3, 321
  7. Sadeghnia, 2013, Protective effect of rutin on hexachlorobutadiene-induced nephrotoxicity, Renal Fail., 35, 1151, 10.3109/0886022X.2013.815546 · DOI
  8. Janbaz, 2002, Protective effect of rutin on paracetamol-and CCl 4-induced hepatotoxicity in rodents, Fitoterapia, 73, 557, 10.1016/S0367-326X(02)00217-4 · DOI · Paper page
  9. Niture, 2014, Anti-hyperglycemic activity of rutin in streptozotocin-induced diabetic rats: an effect mediated through cytokines, antioxidants and lipid biomarkers, Ind. J. Exp. Biol., 52, 720
  10. Prince, 2006, Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes, J. Biochem. Mol. Toxicol., 20, 96, 10.1002/jbt.20117 · DOI · Paper page
  11. Kamalakkannan, 2006, Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues, Mol. Cell. Biochem., 293, 211, 10.1007/s11010-006-9244-1 · DOI · Paper page
  12. Prince, 2006, Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats, J. Pharm. Pharmacol., 58, 1373, 10.1211/jpp.58.10.0011 · DOI
  13. Alsaif, 2009, Beneficial effects of rutin and vitamin C coadministration in a streptozotocin-induced diabetes rat model of kidney nephrotoxicity, Pak. J. Nutr., 8, 745, 10.3923/pjn.2009.745.754 · DOI
  14. Ola, 2015, Neuroprotective effects of rutin in streptozotocin-induced diabetic rat retina, J. Mol. Neurosci., 56, 440, 10.1007/s12031-015-0561-2 · DOI
  15. Al-Enazi, 2014, Protective effects of combined therapy of Rutin with Silymarin on experimentally-induced diabetic neuropathy in rats, Pharmacol. Pharm., 5, 876, 10.4236/pp.2014.59098 · DOI
  16. Saklani, 2016, Cardioprotective effects of rutin via alteration in TNF-α, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats, Mol. Cell. Biochem., 420, 65, 10.1007/s11010-016-2767-1 · DOI
  17. Fernandes, 2010, Influence of rutin treatment on biochemical alterations in experimental diabetes, Biomed. Pharmacother., 64, 214, 10.1016/j.biopha.2009.08.007 · DOI · Paper page
  18. Tian, 2016, Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats, Eur. J. Pharmacol., 771, 84, 10.1016/j.ejphar.2015.12.021 · DOI
  19. Guimaraes, 2015, Rutin administration attenuates myocardial dysfunction in diabetic rats, Cardiovasc. Diabetol., 14, 90, 10.1186/s12933-015-0255-7 · DOI
  20. Wang, 2015, Rutin alleviates diabetic cardiomyopathy in a rat model of type 2 diabetes, Exp. Ther. Med., 9, 451, 10.3892/etm.2014.2090 · DOI
  21. Akondi, 2011, Protective effect of Rutin and Naringin on sperm quality in streptozotocin (STZ) induced type 1 diabetic rats, Iran. J. Pharm. Res., 10, 585
  22. Hao, 2012, Preventive effects of rutin on the development of experimental diabetic nephropathy in rats, Life Sci., 91, 959, 10.1016/j.lfs.2012.09.003 · DOI
  23. Chu, 2010, Protective effect of rutin from buckwheat flowers and leaves on hepatic injury at early stage in diabetic rats, Jiangsu Med. J., 8, 026
  24. Gao, 2015, Role of tissue transglutaminase in the pathogenesis of diabetic cardiomyopathy and the intervention effect of rutin, Exp. Ther. Med., 9, 1103, 10.3892/etm.2015.2223 · doi:10.3892/etm.2015.2223
  25. Bais, 2017, Evaluation of effect of rutin in diabetes rat gastropathy, Int. J. Pharm. Phytopharmacol. Res., 1, 363
  26. Jadhav, 2012, Hypoglycemic and antidiabetic activity of flavonoids: boswellic acid, ellagic acid, quercetin, rutin on streptozotocin-nicotinamide induced type 2 diabetic rats, Int. J. Pharm. Pharm. Sci., 4, 251
  27. Hunyadi, 2012, Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats, PLoS One, 7, e50619, 10.1371/journal.pone.0050619 · DOI · Paper page
  28. Hsu, 2014, Rutin potentiates insulin receptor kinase to enhance insulin-dependent glucose transporter 4 translocation, Mol. Nutr. Food Res., 58, 1168, 10.1002/mnfr.201300691 · DOI
  29. Srinivasan, 2005, Partial protective effect of rutin on multiple low dose streptozotocin-induced diabetes in mice, Ind. J. Pharmacol., 37, 327, 10.4103/0253-7613.16859 · doi:10.4103/0253-7613.16859
  30. Dake, 2016, Diabetic dyslipidemia review: an update on current concepts and management guidelines of diabetic dyslipidemia, Am. J. Med. Sci., 351, 361, 10.1016/j.amjms.2016.01.020 · DOI
  31. Ghorbani, 2014, Clinical and experimental studies on polyherbal formulations for diabetes: current status and future prospective, J. Integr. Med., 12, 336, 10.1016/S2095-4964(14)60031-5 · DOI
  32. Ghorbani, 2013, Best herbs for managing diabetes: a review of clinical studies, Braz. J. Pharm. Sci., 49, 413, 10.1590/S1984-82502013000300003 · DOI
  33. Ghorbani, 2013, Phytotherapy for diabetic dyslipidemia: evidence from clinical trials, Clin. Lipidol., 8, 311, 10.2217/clp.13.26 · DOI
  34. Ahmed, 2010, Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Ruta graveolens infusion and rutin in nicotinamide-streptozotocin-induced diabetic rats, Diabetol. Croat., 39, 15
  35. Sattanathan, 2011, Beneficial health effects of rutin supplementation in patients with diabetes mellitus, J. Appl. Pharm. Sci., 1, 227
  36. Li, 2009, Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of α-glucosidase, J. Agric. Food Chem., 57, 11463, 10.1021/jf903083h · DOI · Paper page
  37. Jo, 2009, Comparison of antioxidant potential and rat intestinal α-glucosidases inhibitory activities of quercetin, rutin, and isoquercetin, Int. J. Appl. Res. Nat. Prod., 2, 52
  38. Esmaeili, 2009, Antioxidant and protective effects of major flavonoids from Teucrium polium on β-cell destruction in a model of streptozotocin-induced diabetes, Planta Med., 75, 1418, 10.1055/s-0029-1185704 · doi:10.1055/s-0029-1185704
  39. Cai, 2009, Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic β cells, J. Agric. Food Chem., 57, 9817, 10.1021/jf902618v · DOI · Paper page
  40. Kappel, 2013, Involvement of GLUT-4 in the stimulatory effect of rutin on glucose uptake in rat soleus muscle, J. Pharm. Pharmacol., 65, 1179, 10.1111/jphp.12066 · DOI
  41. Khan, 2002, Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways, Diabetologia, 45, 1475, 10.1007/s00125-002-0974-7 · DOI · Paper page
  42. Boden, 2001, Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus, Am. J. Physiol. Endocrinol. Metab., 280, E23, 10.1152/ajpendo.2001.280.1.E23 · DOI · Paper page
  43. Barthel, 2003, Novel concepts in insulin regulation of hepatic gluconeogenesis, Am. J. Physiol. Endocrinol. Metab., 285, E685, 10.1152/ajpendo.00253.2003 · DOI · Paper page
  44. Hosseini, 2015, Pancreatic beta cell protection/regeneration with phytotherapy, Braz. J. Pharm. Sci., 51, 1, 10.1590/S1984-82502015000100001 · DOI
  45. Brownlee, 2005, The pathobiology of diabetic complications, Diabetes, 54, 1615, 10.2337/diabetes.54.6.1615 · DOI · Paper page
  46. Singh, 2014, Advanced glycation end products and diabetic complications, Korean J. Physiol. Pharm., 18, 1, 10.4196/kjpp.2014.18.1.1 · DOI · Paper page
  47. Vetter, 2015, Glycated serum albumin and AGE receptors, Adv. Clin. Chem., 72, 205, 10.1016/bs.acc.2015.07.005 · DOI
  48. Nagasawa, 2003, Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative, Mol. Cell. Biochem., 249, 3, 10.1023/A:1024793429244 · DOI
  49. Laurean, 2007, Rutin derivatives as potent AGE inhibitors and its relevance in diabetes complications, FASEB J., 21, A633, 10.1096/fasebj.21.5.A633-a · doi:10.1096/fasebj.21.5.a633-a
  50. Muthenna, 2012, Inhibition of advanced glycation end-product formation on eye lens protein by rutin, Br. J. Nutr., 107, 941, 10.1017/S0007114511004077 · DOI
  51. Nagasawa, 2003, Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats, Mol. Cell. Biochem., 252, 141, 10.1023/A:1025563519088 · DOI
  52. Kamalakkannan, 2006, The influence of rutin on the extracellular matrix in streptozotocin-induced diabetic rat kidney, J. Pharm. Pharmacol., 58, 1091, 10.1211/jpp.58.8.0010 · DOI
  53. Geraldes, 2010, Activation of protein kinase C isoforms and its impact on diabetic complications, Circ. Res., 106, 1319, 10.1161/CIRCRESAHA.110.217117 · DOI · Paper page
  54. Reddy, 2011, Inhibition of aldose reductase and sorbitol accumulation by dietary rutin, Curr. Sci., 101, 1191
  55. Cao, 1997, Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships, Free Radical Biol. Med., 22, 749, 10.1016/S0891-5849(96)00351-6 · DOI · Paper page
  56. Ghiasi, 2011, Quantum mechanical study of antioxidative ability and antioxidative mechanism of rutin (vitamin P) in solution, Carbohydr. Res., 346, 739, 10.1016/j.carres.2011.01.021 · doi:10.1016/j.carres.2011.01.021
  57. Das, 2016, Polyphenol compounds and PKC signaling, Biochem. Biophys. Acta, 1860, 2107, 10.1016/j.bbagen.2016.06.022 · DOI
  58. Ferriola, 1989, Protein kinase C inhibition by plant flavonoids: kinetic mechanisms and structure-activity relationships, Biochem. Pharmacol., 38, 1617, 10.1016/0006-2952(89)90309-2 · DOI · Paper page
  59. End, 1987, Non-selective inhibition of mammalian protein kinases by flavinoids in vitro, Res. Commun. Chem. Pathol. Pharmacol., 56, 75
  60. Sprague, 2009, Inflammatory cytokines in vascular dysfunction and vascular disease, Biochem. Pharmacol., 78, 539, 10.1016/j.bcp.2009.04.029 · DOI · Paper page
  61. Dronavalli, 2008, The pathogenesis of diabetic nephropathy, Nat. Rev. Endocrinol., 4, 444, 10.1038/ncpendmet0894 · DOI · Paper page
  62. Schena, 2005, Pathogenetic mechanisms of diabetic nephropathy, J. Am. Soc. Nephrol., 16, S30, 10.1681/ASN.2004110970 · DOI · Paper page
  63. Hu, 2009, Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement, Am. J. Physiol. Renal Physiol., 297, F1080, 10.1152/ajprenal.90767.2008 · DOI
  64. Rauter, 2010, Antihyperglycaemic and protective effects of flavonoids on streptozotocin-induced diabetic rats, Phytother. Res., 24, 10.1002/ptr.3017 · DOI
  65. Xu, 2014, A glimpse of matrix metalloproteinases in diabetic nephropathy, Curr. Med. Chem., 21, 3244, 10.2174/0929867321666140716092052 · DOI
  66. Pu, 2007, Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats, J. Pharmacol. Sci., 104, 329, 10.1254/jphs.FP0070247 · DOI · Paper page
  67. Amarapurkar, 2002, Chronic liver disease in diabetes mellitus, Trop. Gastroenterol., 23, 3
  68. Harrison, 2006, Liver disease in patients with diabetes mellitus, J. Clin. Gastroenterol., 40, 68, 10.1097/01.mcg.0000190774.91875.d2 · DOI · Paper page
  69. Arkkila, 2001, Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes, Diabetes Res. Clin. Pract., 52, 113, 10.1016/S0168-8227(00)00241-2 · doi:10.1016/s0168-8227(00)00241-2
  70. Lucchesi, 2013, Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease, Acta Cir. Bras., 28, 502, 10.1590/S0102-86502013000700005 · DOI
  71. Kakkar, 1998, Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes, Clin. Sci., 94, 623, 10.1042/cs0940623 · DOI · Paper page
  72. Stolar, 2003, Type 2 diabetes cardiovascular risk, and the link to insulin resistance, Clin. Ther., 25, B4, 10.1016/S0149-2918(03)80240-0 · DOI
  73. Shah, 2016, Molecular and cellular mechanisms of cardiovascular disorders in diabetes, Circ. Res., 118, 1808, 10.1161/CIRCRESAHA.116.306923 · DOI · Paper page
  74. Krishna, 2005, Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats, Can. J. Physiol. Pharmacol., 83, 343, 10.1139/y05-009 · DOI
  75. Challa, 2011, Partial role of nitric oxide in infarct size limiting effect of quercetin and rutin against ischemia-reperfusion injury in normal and diabetic rats, Ind. J. Exp. Biol., 49, 207
  76. Annapurna, 2009, Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats, J. Pharm. Pharmacol., 61, 1365, 10.1211/jpp.61.10.0014 · DOI
  77. Graefe, 1999, Relative systemic availability of the flavonoids quercetin and rutin in humans, Arch. Pharm. Pharm. Med. Chem., 332, 20
  78. Al-Roujeaie, 2016, Effect of rutin on diabetic-induced erectile dysfunction: possible involvement of testicular biomarkers in male rats, Andrologia, 1

Cited by

See all 511

Metadata

Authors
Ghorbani, A.
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2017-12
Volume
96
Pages
305-312
ISSN
0753-3322
Cited by
511
References
2
Language
en
Funders
Vice Chancellery for Research and Technology, Mashhad University of Medical Sciences, Mashhad, Iran

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of antidiabetic effects of flavonoid rutin. https://app.cochat.ai/papers/10.1016/j.biopha.2017.10.001
The paper
Ghorbani, A. (2017). Mechanisms of antidiabetic effects of flavonoid rutin. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2017.10.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.